While continuation vehicles offer significant strategic benefits, they involve several complex risks and challenges that both General Partners (GPs) and Limited Partners (LPs) must navigate:
- Inherent Conflicts of Interest: The primary risk stems from the GP serving as both the seller (on behalf of the existing fund) and the buyer (as the sponsor of the new continuation vehicle). This dual role can create friction regarding deal terms and asset management.
- Valuation Difficulties: Because these transactions involve inherently illiquid assets, determining a fair market price is challenging. Ensuring the transaction occurs at a fair value requires rigorous third-party valuation work and independent fairness opinions to protect all stakeholders.
- Complex Fee Structures: Investors must scrutinize the impact of management fees, transaction-related costs, and carried interest calculations. There is a risk that these fees could negatively impact net returns if not structured transparently.
- Alignment and Oversight Issues: There are risks regarding whether the GP’s incentives truly align with the LPs. This includes the level of GP co-investment and the independence of the oversight committee or advisory board in mitigating conflicts.
- Regulatory Requirements: All transactions must adhere to FINRA regulatory compliance standards and SEC frameworks. Failure to provide transparent disclosures or follow fair-dealing obligations can lead to regulatory and legal complications.
Related FAQs
-
What does M&a Due Diligence Typically Involve?
Read More »: What does M&a Due Diligence Typically Involve?As a Boutique M&A and Capital Advisory Firm, we approach M&A due diligence as a rigorous, three-phase process designed to mitigate risk and uncover hidden value. Our Full-Cycle M&A advisory ensures that every transaction is supported by data-driven confidence. Typically,…
-
How do Regulatory Changes Affect Healthcare M&a Deals?
Read More »: How do Regulatory Changes Affect Healthcare M&a Deals?Regulatory changes act as a fundamental driver in the healthcare sector, directly shaping deal timelines, valuation methodologies, and the overall feasibility of transactions. As a Boutique M&A and Capital Advisory Firm, we observe that these shifts require rigorous financial analysis…
-
What are the Key Trends in Healthcare Mergers and Acquisitions over the past Three Months?
Read More »: What are the Key Trends in Healthcare Mergers and Acquisitions over the past Three Months?The healthcare mergers and acquisitions landscape is currently defined by a fundamental transformation driven by private equity involvement, technological convergence, and shifting regulatory frameworks. In our role as a Boutique M&A and Capital Advisory Firm, we observe several key trends…
-
How Much does a Tech M&a Deal Typically Cost for Advisory Services?
Read More »: How Much does a Tech M&a Deal Typically Cost for Advisory Services?Advisory fees for technology mergers and acquisitions generally follow two primary models. The specific cost depends on the transaction value and the level of service required. The standard structures include: While specific percentages or dollar amounts vary based on the…
-
What are the Key Steps Involved in Tech Mergers and Acquisitions?
Read More »: What are the Key Steps Involved in Tech Mergers and Acquisitions?Navigating technology mergers and acquisitions requires a structured framework designed to manage complexity and maximize value. The process involves several critical milestones: Related FAQs